Back to Search
DAVID HENDERSON, M.D.
M.D.
Internal Medicine Physician
NPI: 1306995527IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
E3000(AR)
Education
UNIVERSITY OF ARKANSAS COLLEGE OF MEDICINE
Class of 1998
Clinical Trials (6)
6
Linked Trials
0
Recruiting
6
With Results
Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus
NCT00351000COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment
NCT00337350COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia
NCT00345033COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia
NCT01082588COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
A Placebo-Controlled, Cross-Over Trial of Aripiprazole
NCT00351936COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia
NCT00595504COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.
PMID 19640511·Biol Psychiatry·2009
3-trial
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.
PMID 18172019·Am J Psychiatry·2008
4-observational
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization.
PMID 18172018·Am J Psychiatry·2008
4-observational
Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review.
PMID 18005941·Biol Psychiatry·2008
1-meta
Inflammatory markers and the risk of Alzheimer disease: the Framingham Study.
PMID 17536046·Neurology·2007
8-other
Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia.
PMID 17112596·Psychiatry Res·2007
8-other
C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia.
PMID 17490859·Schizophr Res·2007
8-other
Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.
PMID 16710316·Neuropsychopharmacology·2007
7-preclinical
Systemic infections and inflammation affect chronic neurodegeneration.
PMID 17220915·Nat Rev Immunol·2007
6-review
Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
PMID 17015817·Arch Gen Psychiatry·2006
4-observational
Higher fasting serum insulin is associated with increased resting energy expenditure in nondiabetic schizophrenia patients.
PMID 16920075·Biol Psychiatry·2006
8-other
Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis.
PMID 16841629·J Clin Psychiatry·2006
4-observational
An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia.
PMID 16423166·Acta Psychiatr Scand·2006
3-trial
Statins of different brain penetrability differentially affect CSF PLTP activity.
PMID 16960448·Dement Geriatr Cogn Disord·2006
2-rct
Does intensive statin therapy lower mortality and cardiovascular event risk in patients with acute coronary syndrome?
PMID 16265333·Nat Clin Pract Cardiovasc Med·2005
8-other
Metabolic effects of melatonin on oxidative stress and diabetes mellitus.
PMID 16217126·Endocrine·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 531 POLK 77
MENA, AR 71953 - Phone
- (479) 437-3602
Quick Facts
- NPI
- 1306995527
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Clinical Trials
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile